Profil
Toshinari Tamura served as a Representative Director at Yamanouchi Pharmaceutical Co., Ltd.
He was also a Director, Chief Science Officer & Executive VP at Astellas Pharma, Inc. Tamura served as an Independent Director at FibroGen, Inc. from 2008 to 2020.
He was also a Director at IMMD, Inc. from 2010 to 2012 and at KinoPharma, Inc. from 2008 to 2010.
Tamura received his undergraduate degree from Chiba University and his graduate and doctorate degrees from the Graduate School of Pharmaceutical Sciences University of Tokyo.
Anciens postes connus de Toshinari Tamura
| Sociétés | Poste | Fin |
|---|---|---|
| FIBROGEN, INC. | Directeur/Membre du Conseil | 04/06/2020 |
IMMD, Inc.
 IMMD, Inc. BiotechnologyHealth Technology IMMD, Inc. provides drug discovery research for pharmaceutical companies. It identifies drug seeds by virtual screening, to select promising seeds and to optimize the seeds by minimum syntheses, based on estimated docking mode to the target. The firm also establishes a drug discovery method using software system for rational drug design based on 3-D structures of target proteins. Its business activities also include collaborative drug discovery researches, in-house drug discovery program, and drug seeds. The company was founded by Akiko Itai on March 16, 1995 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | 01/11/2012 |
KinoPharma, Inc.
 KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | 01/03/2010 |
| ASTELLAS PHARMA INC. | Directeur/Membre du Conseil | 01/06/2008 |
Yamanouchi Pharmaceutical Co., Ltd.
 Yamanouchi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP | Directeur/Membre du Conseil | - |
Formation de Toshinari Tamura
| Chiba University | Undergraduate Degree |
| Graduate School of Pharmaceutical Sciences University of Tokyo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Yamanouchi Pharmaceutical Co., Ltd.
Yamanouchi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP | Health Technology |
IMMD, Inc.
IMMD, Inc. BiotechnologyHealth Technology IMMD, Inc. provides drug discovery research for pharmaceutical companies. It identifies drug seeds by virtual screening, to select promising seeds and to optimize the seeds by minimum syntheses, based on estimated docking mode to the target. The firm also establishes a drug discovery method using software system for rational drug design based on 3-D structures of target proteins. Its business activities also include collaborative drug discovery researches, in-house drug discovery program, and drug seeds. The company was founded by Akiko Itai on March 16, 1995 and is headquartered in Tokyo, Japan. | Health Technology |
KinoPharma, Inc.
KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Health Technology |
